Interest in Rh testing and Rh immunoglobulin treatment among patients obtaining telehealth medication abortion.

Saved in:
Bibliographic Details
Title: Interest in Rh testing and Rh immunoglobulin treatment among patients obtaining telehealth medication abortion.
Authors: Shin LJ; School of Medicine, California University of Science and Medicine, Colton, CA, United States., Koenig LR; Advancing New Standards in Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States., Ko J; Advancing New Standards in Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States., Meckstroth K; Advancing New Standards in Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States., Upadhyay UD; Advancing New Standards in Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States; Center for Gender and Health Justice, University of California Global Health Institute, San Francisco, CA, United States. Electronic address: Ushma.upadhyay@ucsf.edu.
Source: Contraception [Contraception] 2025 Jun; Vol. 146, pp. 110856. Date of Electronic Publication: 2025 Feb 26.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0518 (Electronic) Linking ISSN: 00107824 NLM ISO Abbreviation: Contraception Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0518
DOI:10.1016/j.contraception.2025.110856